Did someone say #RateReview? Here's a site we set up a few years ago. consumersunion.org/rate-review-re… Haven't had time to update this year, but the info about how rates are reviewed still holds. Check out our blog series and the comments we submitted in California.
Want to have your say about proposed rates in your state? Here's some guides: consumersunion.org/rate-review-fo…. A state can actually block unfair increases with "prior approval" rate review.
States like CA, which are "file and use" rate review technically can't block an unfair rate increase, but CA has used its muscle to negotiate down those bad increases. Check this out from @CALPIRGcalpirg.org/reports/cap/ca…
The timeline for #ratereview varies -- it's always during the summer, but rate proposals will be revealed between now (VA, MD) and end of the summer (CA).
Don't get me started on rate filings that redact critical information. OK, I'm started...here's what we said in Health Affairs a few years ago: healthaffairs.org/do/10.1377/hbl…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
In our post, we detail the laudable advances put forward in the @AmerMedicalAssn's Privacy Principles, including principles on: increasing transparency, increasing health equity, and precautions against digital phenotyping. (2/4)
We also detail key differences between AMA's principles and HIPAA regulations. If you like comparison tables, you're in luck! We made a side-by-side comparison of the AMA Privacy Principles and HIPAA. (3/4) static1.squarespace.com/static/5be4eaf…
Wearables and in-home sensors offer great promise for affordable, accessible, equitable, high-quality care. But the data creates a safety issue that extends beyond the body. Want to learn more? Check out @GoldsackJen@_DiMeSociety and my latest blog bit.ly/2YeTcDL
Professional codes of ethics, laws, and regulations set patient privacy protections within healthcare. For good reason: patients should control access their health information.
But shaky data rights in the U.S. mean health tech could unwittingly putting patients' data at risk.
It’s time that data rights are central to our definition of “patient safety.” Specifically, we propose that patient safety in the digital era be redefined to include the risk of harm to individuals through digital health technologies and the data they generate.
Consumers feel like they have little control over data collected on them. Users of #reprohealth apps have reason to be wary. @ConsumerReports tested 5 apps and found shortcomings in the way all handle the sensitive user data they collect. cr.org/periodtrackers
Repro health apps are offered as an empowerment tool for consumers eager for power and agency over their health. Yet at the same time, many health apps do not have proper privacy standards in place, which too often results in sensitive health data falling into the wrong hands.
US privacy laws are a safety net with more gaps than coverage. Health privacy laws that consumers rely on to protect sensitive details abt themselves do not extend to health tech like repro health apps. The bar is low. As a purveyor of wellness, app developers should aim higher
Your regular reminder that HIPAA + other health privacy laws don’t apply to DTC genetic testing companies. When you take a test, you share your family genetic info. When you test your kid, you make a choice about their privacy that can't be undone when they're older.
.@CRAdvocacy supports @ab824, which would help ensure that the pathways for entry by affordable generic alternatives stay open, so that budget-conscious consumers will have choices, and will not have to continue paying unjust monopoly prices for the medications they need. 1/4
What we're talking about here is prohibiting anti-competitive "pay for delay" schemes, where brand-name prescription drug makers effectively pay-off makers of more affordable generic (or biosimilar) alternatives so the brand-name drug maker can prolong its monopoly profits. 2/4
.@ConsumerReports has covered the issue of Rx affordability many times over the years. This recent article re-confirmed that escalating Rx costs force many consumers to choose between cutting back on needed medications or on other basic necessities. consumerreports.org/drug-prices/ho… 3/4
Wellness programs are promoted as improving wellness, and they’re having a moment. But, they may not be a fair deal for enrollees. @ConsumerReports explains why wellness programs may not be all they appear. consumerreports.org/health-privacy…
Last year, 82% of larger companies & 53% of smaller firms offered some type of wellness program kff.org/health-costs/r…
But, problems lurk just below the surface of wellness programs.